Efrat Ben-Zeev

Efrat Ben-Zeev serves as a representative on the Scientific Advisory Committee to the Israel Research Core Facilities (IRCF) since January 2024 and has been a Cheminformatic & Computational Chemist Specialist at the Weizmann Institute of Science since August 2012. Prior experience includes roles as a Senior Scientist in Computational Drug Discovery at Dynamix Pharmaceuticals from February 2009 to May 2012, a Scientist in Computational Drug Discovery at EPIX Pharmaceuticals from April 2005 to November 2008, and a position focused on Computational Drug Development at Predix Pharmaceuticals during the same timeframe. Efrat Ben-Zeev completed a Ph.D. in Computational Chemistry/Biology at the Weizmann Institute of Science from 2000 to 2005, following an MSc from Tel Aviv University earned between 1993 and 1998.